TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) — Greenridez 2.0 Acquisitions Corp. (the “Company”) is pleased to announce that it has completed its acquisition…
Continue readingG2 Acquires Lophos Pharma, a peyote focused psychedelics company
More Lawyers Are Addressing Twin Stigmas of Mental Health and Psychedelics | The American Lawyer
A Winston & Strawn associate opened the door. Now Katten’s CEO is speaking up.
Continue readingWhat to Expect in Neuroscience, Genetics, Longevity, Biotech, and Psychedelics in 2022 – NEO.LIFE
We ask the experts what’s coming in the next 12 months.
Continue readingWhat are the potential risks of microdosing psychedelics?
Microdosing psychedelics has become a popular wellness trend, but is it really that beneficial? Learn more on the science of how much you take and how often you take psychedelics.
Continue readingPsychedelics biotech set to go public via SPAC — pushing IV form of psilocybin into PhI
Psychedelics biotech Eleusis has its eyes on an expansion, and it’s going the SPAC route to get it. The biotech announced earlier today that it’s teaming up with a SPAC born out of asset manager Silver Spike Capital to make Eleusis a public company. Once the deal goes through sometime
Continue readingPsychedelics company Eleusis to go public through SPAC Silver Spike Acquisition Corp. II
Psychedelics sciences firm Eleusis plans to go public through a deal with SPAC Spike Acquisition Corp. II (SPKB) in a deal that give the combined company an enterprise value of $446M
Continue readingPsychedelics Are The Hot Conference Topic
It wasn’t that long ago when psychedelics emerged as a potentially better natural plant-based medicine for treating such things as treatment-resistant depression (TRD), into what is now a billion-dollar juggernaut of an industry. Then an even curiouser thing happened. Around 2015, organizers of more and more conferences about cannabis—and some that were not about cannabis […]
Continue readingPsychedelics Firm Eleusis Goes Public Via Merger With Silver Spike Acquisition Creating $450M Company | Benzinga
British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“S…
Continue readingPsychedelics & MDMA are finally being legalised for mental health therapy
One psychologist called it “the greatest leap forward in mental health care since the invention of psychotherapy.”
Continue readingHow 2021 became the year of psychedelics – and why 2022 is set to be even bigger
It’s no secret that psychedelics are on the comeback trail, with a record number of trials and total investment in the hundreds of millions of dollars in
Continue reading